Adagio Medical Holdings
web2Adagio Medical Holdings is an American medical technology company developing catheter based abl...
About
Adagio Medical Holdings is an American medical technology company developing catheter based ablation systems intended to treat abnormal heart rhythms, particularly ventricular tachycardia. Its proprietary Ultra Low Temperature Ablation technology uses extreme cold to create targeted lesions in cardiac tissue responsible for abnormal electrical signals. The company's principal product program centers on its vCLAS Ventricular Ablation System, which has undergone clinical evaluation and regulatory review. Adagio is also developing a subsequent catheter platform intended to improve procedural handling and treatment delivery. Its research includes a combined pulsed field and cryoablation technology platform. Commercial activities remain limited while the company pursues product development and regulatory authorization.
Explore this sector
Exchange listings
Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.
Adagio Medical Holdings profile.
Expert coverage
No published expert evaluations are available for this project yet.
Orbitrum Academy